Cochlear Limited operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cochlear Limited with three other
medical equipment manufacturers in Australasia:
Compumedics Limited
(2021
sales of 35.74 million Australian Dollars [US$25.97 million]
),
Genetic Signatures Ltd
(28.59 million Australian Dollars [US$20.78 million]
of which 100%
was Genetic signatures to identify diseases ), and
Nanosonics Limited
(103.08 million Australian Dollars [US$74.91 million]
of which 100%
was single operating segment).
Sales Analysis.
Cochlear Limited reported sales of A$1.50 billion (US$1.09 billion)
for the
fiscal
year ending
June of 2021.
This
represents
an
increase of 13.4%
versus 2020, when the company's sales were A$1.32 billion.
Sales of Asia Pacific saw an increase
of
12.8% in 2021, from
A$222.40 million to A$250.80 million.